Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$36,954,437
+$16,450,975 QoQ
Shares Held
301,472
+55.0% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#37
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Sep 30, 2025CallValue
$13,751
CallShares
207
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. PTGX ranks #30 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in PTGX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,954,437 | 301,472 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $20,503,462 | 194,530 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,538,707 | 97,764 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $13,751 | 207 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $872,690 | 13,137 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,069 | 146 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $505,112 | 9,139 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $685,212 | 14,169 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $751,349 | 19,465 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $913,230 | 20,294 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $128,101 | 3,697 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,366,450 | 47,233 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,648,621 | 71,898 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,401,319 | 143,964 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,587,802 | 202,310 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $5,465,352 | 237,624 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $993,082 | 91,025 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,991,697 | 236,263 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $345,168 | 43,637 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $453,424 | 19,148 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $1,322,103 | 38,658 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $141,884 | 8,007 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $71,852 | 1,601 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $120,124 | 4,638 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $148,075 | 7,345 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $138,922 | 7,106 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $15,116 | 856 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $38,731 | 5,486 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||